Physician
Dermatology
Dr. Gottfried Schmer, MD
|
|
Give Review
Gottfried Schmer, MD is an expert in the field of Dermatology. Gottfried Schmer is also a published doctor. He has 70 paper published. The most recent paper is: A second-generation blood substitute (perfluorodichlorooctane emulsion) does not activate complement during an ex vivo circulation model of bypass.
Publications
- Sir Patrick Manson: good medicine for the people of Hong Kong.
- Elimination of an artificial immune complex by plasmapheresis in rabbits.
- A second-generation blood substitute (perfluorodichlorooctane emulsion) does not activate complement during an ex vivo circulation model of bypass.
- Needle aspiration of an intracerebral hemorrhage complicating thrombolytic therapy for myocardial infarction.
- The synthesis of a water soluble complement activating polyacrylic acid-IgG polymer.
- Brief report: fatal hemorrhage in a patient with an acquired inhibitor of human thrombin.
- Influence of C1q on the interaction of model immune complexes with human platelets.
- Binding of heparin to antithrombin III: The use of dansyl and rhodamine labels.
- A method for monitoring antifibrinolytic therapy in patients with ruptured intracranial aneurysms.
- Platelet kinetics during deep hypothermia.
- Removal of low density lipoproteins in sheep by extracorporeal affinity chromatography.
- The bio-artificial organ: review and progress report.
- Successful use of two new reactor types in sheep.
- Successful in vivo experiments in sheep using a new nonhydrolyzable enzyme reactor resistant against tryptic digestion.
- Immunohistochemical identification of mast cells in paraffin- and epon-embedded tissues using platelet factor 41.
- Synthesis of enzyme reactors consisting of xenocells.
- Glutaraldehyde-treated xenocells: a specific adsorbent for complement factors.
- Application of mechanical impedance measurements to the study of dysfibrinogens.
- Fibrinogen Seattle releases half the normal amount of fibrinopeptide B.
- Isolation, characterization, and propagation in vitro of human glomerular endothelial cells.
- [Experimental plasmin arthritis].
- Successful long-term use of a plasmapheresis reactor system in dogs with Lymphoma.
- Fingerprints of DNS-labeled protein digests on a millimicromole scale.
- On the purification factor VII from bovine plasma.
- Micro method for detection of formyl and acetyl groups in proteins.
- The isolation nd characterization of bovine factor VIII (antihemophilic factor).
- A solid-phase radioassay for plasminogen in human plasma.
- Hollow fiber artificial kidney (hfak) dialysis without parenteral heparin.
- A solid-phase radioassay for factor-XIII activity (fibrin stabilizing factor) in human plasma.
- Isolation and characterization of human Factor VIII (antihemophilic factor).
- The biological activity of covalently immobilized heparin.
- Covalent binding of biomolecules to radiation-grafted hydrogels on inert polymer surfaces.
- A simple 2-step isolation procedure for human antithrombin II/III and its biological activity after insolubilization to agarose.
- The prufication of bovine thrombin by affinity chromatography on benzamidine-agarose.
- [Quantitative determination of 10-4micro Mol N-terminal amino acids in immunoglobulins by labelling with 1-dimethylamino-naphthalene-5-sulfonyl chloride].
- Fibrinogen Seattle II: defective release of fibrinopeptide A in a slow clotting fibrinogen.
- Evaluation of a new dynamic viscometer for measuring the viscosity of whole blood and plasma.
- Hemodynamic measurements in a sheep model with a hollow fiber artificial kidney containing modified cellulose.
- Accurate coagulation studies from heparinized radial artery catheters.
- Estimation of surface-bound heparin activity: a comparison of methods.
- Enzyme reactors for the removal of amino acids from plasma.
- Successful long-term use of a miniaturized plasmapheresis circuit in rabbits.
- Standardization of methods for measuring plasminogen activator inhibitor activity in human plasma.
- Optimum conditions for the stabilization and measurement of tissue plasminogen activator activity in human plasma.
- Diurnal variation of tissue-type plasminogen activator and its rapid inhibitor (PAI-1).
- The synthesis of L-tryptophan degrading bioreactors.
- Consumption of complement and activation of human neutrophils by an artificial immune complex: polyacrylic acid-IgG-polymer.
- Liquid phase enzyme reactor, a new bioreactor principle.
- Inhibition of bovine factor IXa and factor Xabeta by antithrombin III.
- Characterization of human, bovine, and horse antithrombin III.
- Ultrasonic measurement of blood coagulation time.
- Proceedings: Affinity of antithrombin II/III to insolubilized heparin.
- Biologic and physical properties of succinylated and glycosylated Acinetobacter glutaminase-asparaginase.
- Successful use of heparin-grafted hollow fiber dialyzers in sheep.
- Successful use of a totally heparin grafted hemodialysis system in sheep.
- Gel-bound resealed red cell membranes: a new type of semi-artificial organ.
- Clinical use of a totally heparin grafted hemodialysis system in uremic patients.
- Isolation, crystallization, and primary amino acid sequence of human platelet factor 4.
- Fibrinogen Seattle: a qualitatively abnormal fibrinogen in a patient with tetralogy of Fallot.
- Use of athrombogenic tubing for perfusion rewarming following surface-induced deep hypothermia.
- Heparin binding to antithrombin III: variation in binding sites and affinity.
- Purification of indolyl-3-alkane alpha-hydroxylase by affinity chromatography on indolyl-agarose columns.
- Kinetics of uptake and activity in mouse liver of glutaminase coupled to desialated orosomucoid.
- Isolation of high-activity heparin by DEAE-Sephadex and protamine-Sepharose chromatography.
- Induction of hypothermia in mice by semi-artificial cells containing indolyl-3-alkane alpha-hydroxylase.
- Complement consumption in acute disseminated intravascular coagulation without antecedent immunopathology.
- A solid-phase radioassay for the quantitative determination of antiplasmin activity in human plasma.
- A simple two-step isolation procedure for human and bovine antithrombin II/III (heparin cofactor): a comparison of two methods.
- Molecular engineering of the L-tryptophan-depleting enzyme indolyl-3-alkane alpha-hydroxylase.
Conditions Treated
- Lymphoma
Doctors Specialties
- Hematology
- Dermatology
Accepted Insurances
- Blue Card PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Coop Core
- ODS Health Plan
- Preferred Provider Network PPN
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
Helpful Reviews
Similar Doctors
|
Dr. Kelli R. Arntzen, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Junko Takeshita, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Aashiyana F. Koreishi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John L. Halloran, MD |
|
|
Dr. Barbara A. Konkle, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Sheldon Widlan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Laurie G. Jacobson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marcos Antezana, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tejaswini M. Dhawale, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jennifer M. Gardner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Ardeth L. Dunne, PA-C |
|
|
Dr. Christina M. Wahlgren, MD
This Doctor is OpenDoctor Recommended.
|